baber/WOPTO huggingface dataset:
Patent CZ-295596-B6 (CZ)
Title: Fuel injection valve for internal combustion engines
Inventor: HARNDORF HORST
IPC: F02M61/16
Filed: 2000-11-24
Abstract: The present invention relates to a fuel injection valve comprising a valve body (1), in which a plunger-shaped valve element (5) is arranged that axially moves counter a closing force inside a boring (2). On a portion of its length turned away from combustion chamber, this valve element (5) is guided in the boring (2) while on a portion arranged away from the guided portion in the direction toward the combustion chamber it is surrounded with a pressure space (11) performed in the valve body (1), being connectable with a high-pressure fuel source, and with a valve element (5) shoulder (18) acting in the opening direction. Said valve element (5) controls, on the end located on the side of the combustion chamber, at least one injection opening (13a, 13b) by means of an opening lifting movement. During the opening lifting movement, the valve element (5) comes to rest on a face of a control plunger (30) that surrounds said valve element (5), said face being configured as a lift stopping face (42). The control plunger (30) delimits, with the stepped face (35) thereof, a control space (33) that can be filled with fuel. When a defined fuel pressure in the control space (33) is reached, the control plunger (30) moves toward the spring space (20) from a first lifting position into a second lifting position, thus limiting the opening lifting movement of the valve element (5) to a partial lift. One part of the control plunger (30) is configured as a piezoelectric actuator (26) whose axial extension is altered by the flow of current, whereby the partial lift of the valve element (5) can be continuously adjusted in the first lifting position of the control plunger (30) within the lift of the piezoelectric actuator (26).
Patent CZ-303172-B6 (CZ)
Title: Crystalline form of p1-(2'-deoxycytidine-5'-)p4-(uridine-5'-)tetraphosphate
Inventor: MORI KENYA
IPC: C07H1/04
Filed: 2000-06-30
Abstract: The present invention relates to a crystalline form of the compound Pe1-(2?-deoxycytidine-5?-)Pe4-(uridine-5?-)tetraphosphate .4Na where one molecule of the Pe1-(2?-deoxycytidine-5?-)Pe4-(uridine-5?-)tetraphosphate .4Na binds or adhesively binds 1 to 15 water molecules, and a process for preparing such crystals. Crystals of the said compound prepared by the method of the invention are very pure, very stable and are not hygroscopic if compared with a lyophilized product, and can be therefore used as a starting material in the preparation of medicaments. The preparation method described herein is further suitable for industrial preparation of the indicated compound.
Patent CZ-303400-B6 (CZ)
Title: Selective crystallization of 3-pyridy1-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate and pharmaceutical composition
Inventor: CAZER FREDRICK DANA
IPC: C07D201/00
Filed: 2001-02-01
Abstract: In the present invention, there is disclosed a process for selectively producing 3-pyridyl-1-hydroxyethlidene-1,1-bisphosphonic acid (risedronate) sodium hemipentahydrate and monohydrate comprising the steps of : a) providing an aqueous solution of 3-pyridyl-1-hydroxyethlidene-1,1 bisphosphonic acid (risedronate) sodium; b) heating the aqueous solution to a temperature from about 45 C to about 75 C; c) adding a solvent to the aqueous solution characterized in that the solvent is selected from the group consisting of alcohols, esters, ethers, ketones, amides, and nitriles; and d) optionally cooling the aqueous solution. There is also disclosed a pharmaceutical composition comprising 3-pyridyl-1-hydroxyethlidene-1,1- bisphosphonic acid (risedronate) sodium characterized in that the 3-pyridyl-l-hydroxyethlidene-1,1- bisphosphonic acid (risedronate) sodium is from about 90% to about 100% hemipentahydrate and from about 10% to about 0% monohydrate.
Patent CZ-296907-B6 (CZ)
Title: Fungicidal mixtures and method for controlling pathogenic fungi using such fungicidal mixtures and use thereof
Inventor: EICKEN KARL
IPC: A01N43/40
Filed: 2001-12-13
Abstract: The present invention relates to fungicidal mixtures containing, in a synergistically active amount, A) amide compounds of the general formula I wherein Re1 and Re2 are the same or different and represent halogen, nitro, cyano, alkyl containing 1 to 8 carbon atoms, alkenyl having 2 to 8 carbon atoms, alkynyl having 2 to 8 carbon atoms, haloalkyl having 2 to 8 carbon atoms, haloalkenyl having 2 to 8 carbon atoms, haloalkynyl containing 2 to 8 carbon atoms, alkoxy with 1 to 8 carbon atoms, haloalkoxy containing 1 to 8 carbon atoms, haloalkylthio having 1 to 8 carbon atoms, alkylsulfinyl or C1-C8 alkylsulfonyl containing each 1 to 8 carbon atoms, x represents between 1 and 4, and y represents between 1 and 5; and B) imidazole derivative of the general formula II wherein Re1 and Re2 represent a halogen and phenyl which can be substituted with a halogen atom, or Re1 and Re2, together with the bridging C=C double bond, form a 3,4-difluoromethylenedioxyphenyl group, Re3 represents a cyano group or a halogen atom, and Re4 represents a dialkylamino group having 1 to 2 carbon atoms in the alkyl moiety or isoxazol-4-yl which can carry two alkyl group containing 1 to 4 carbon atoms. The invention also relates to a method for controlling pathogenic fungi using mixtures of the compounds of the general formula I and II, and the use of the compounds of the general formula I and II for preparing such mixtures.
Patent SK-288376-B6 (SK)
Title: Building element, especially slab shaped and method of its manufacture
Inventor: PLESNIK JURAJ
IPC: E04C2/26
Filed: 2009-06-16
Abstract: Building element, especially slab shaped comprises a mixture of a basic component with additive of recycled material consisting of textile fibres obtained from the pulping process of hard to pulping multi-composite fabrics, which can be supplemented by recycled textile pulp obtained by the recycling of tires.
Patent BR-9609303-B8 (BR)
Inventor: SUTTER GERD
IPC: A61K35/76
Filed: 1996-07-03
Abstract: Recombinant MVA viruses containing and capable of expressing foreign genes which is inserted at the site of a naturally occuring deletion within the MVA genome, and the use of such recombinant MVA viruses for the production of polypeptides, e.g. antigenes or therapeutic agents, and for the production of recombinant viruses for vaccines, or viral vectors for gene therapy.
Patent EP-1665740-B8 (EP)
Inventor: SCHLEGEL THOMAS
IPC: H04M1/04
Filed: 2004-09-08
Granted: 2012-03-14
Abstract: The invention relates to a connection device ( 1 ) which is used to connect mobile radio terminals ( 51, 52, 53 ) to an electronic system ( 2 ) arranged in a vehicle, and a base part ( 3 ) and an adapter part for said type of connection system. The connection system ( 1 ) comprises a base part ( 3 ) which is permanently fixed in the vehicle and one or several retaining parts ( 41, 42 ) for respectively receiving a mobile radio terminal ( 52, 52 ). The base part ( 3 ) comprises a first electric interface ( 11 ) which is connected to a signal processing device ( 2 ) arranged in the vehicle, said device performing at least partial functions of a handsfree device. The base part ( 3 ) also comprises a second mechanical and electrical interface ( 12 ) which is used to connect retaining parts ( 41, 42 ) in order to receive mobile radio terminals ( 51, 52 ), in addition to a communication device ( 5 ) for wireless communication with a mobile radio terminal ( 53 ) via a third interface ( 13 ). The communication device ( 5 ) is configured in such a manner that it communicates with the signal processing device ( 2 ) via a first interface ( 11 ) by means of a first protocol and it converts the first protocol into a third protocol in order to communicate with the mobile radio terminal ( 53 ) via a third interface ( 13 ).
Patent BR-PI0615933-B8 (BR)
Title: implante dental de duas partes
Inventor: JURGEN MEHRHOF
IPC: A61C8/00
Filed: 2006-09-14
Abstract: implante dental de duas partes a invenção refere-se a um implante dental de duas partes com uma parte de implante distal e uma proximal, as quais, em um estado conectadas uma com a outra em um ponto de conexão, são pelo menos indiretamente contíguas uma à outra e, na região do ponto de conexão, apresentam superficies voltadas umas para as outras, em que entre as superficies voltadas umas para as outras da parte de implante distal e da parte de implante proximal é previsto um corpo de vedação que possui faces de vedação voltadas para as superficies, as quais encostam vedantemente em suas superficies voltadas umas para as outras no definitivo estado conectado das duas partes de implante, e, além disto, entre a parte de implante distal e a parte de implante proximal são previstas faces de contato voltadas umas para as outras, as quais, no implante dental montado pronto, se chocam umas sobre as outras e as quais limitam a medida da aproximação das duas superficies voltadas umas para as outras das partes de implante, entre as quais o corpo de vedação é disposto, de modo que as faces de contato definem uma distância mínima das duas superficies voltadas umas para as outras das partes de implante, que é transposta pelo corpo de vedação, em que o corpo de vedação consiste pelo menos parcialmente de um material elástico.
Patent BR-PI0815204-B8 (BR)
Title: dispositivo de administração fecal
Inventor: DANUTA CIOK
IPC: A61F5/44
Filed: 2008-08-08
Abstract: dispositivo de administração fecal e utilização do dispositivo. a presente invenção refere-se a um dispositivo para administração fecal (9), adequado para ligação diretamente à pele perianal entre as nádegas do usuário. o dispositivo utiliza um disco adesivo otimizado (1) para ligar de maneira segura o dispositivo à pele do usuário, de modo que o dispositivo seja mantido em posição por todo o período de utilização, inclusive circunstâncias ou períodos de uso durante os quais o usuário está ativo, isto é, não acamado. além disso, o dispositivo para administração fecal (9) da presente invenção tem a capacidade de aplicação fácil do dispositivo.
Patent BR-PI0903795-B8 (BR)
Title: Sistema de repressão, monitoramento e atendimento a emergências
Inventor: ROGÉRIO ALBERTO DOS REIS
IPC: H04N7/16
Filed: 2009-09-23
Abstract: sistema móvel e autônomo de repressão, monitoramento e emergências.trata do conceito aplicado a um equipamento móvel e autônomo empregado na repressão ao crime, chamados para atendimentos de emergência e monitoramento remoto através da gravação de imagens.áudios e emissão de dados. caracteriza-se por ser capaz de produzir, por si só, efeito moral, no intuito de transmitir à população a confiabilidade de um sistema eficaz de segurança local, um serviço policial de presença ou de patrulhamento que soja eficiente ou ainda que, pela sua simples presença, sirva como instrumento de repressão ao crime e auxilio à chamados de emergências que necessitem de intervenção urgente de órgãos de segurança pública ou privada, atendendo a chamados de socorro como assaltos, perseguições, emergências módicas, acidentes de trânsito, incêndios, catástrofes, etc. o equipamento é provido de dispositivos de captação de imagem. áudio e emissão de dados, dispositivos para registro e análise local de videos,áudio e dados, dispositivo para transmissão de vídeo, áudio e dados online através das redes de dados das operadoras de telefonia, satélite, redes de dados sem fio, redes de dados de fibra ótica, par metálico ou outros meios que cumpram a função. é provido. também, de sistemas de alerta com luzes e sirenes, botão de emergência, dispositivo de captação de áudio bidirecional, sistema de alto-falantes de grande potência, software de análise inteligente de vídeo, áudio e dados.
Patent BR-PI0908406-B8 (BR)
Title: Derivados de quinoxalinona, processo para a preparação dos mesmos, seu uso e composição farmacêutica
Inventor: GERARD BOTTON
IPC: C07D405/04
Filed: 2009-01-15
Abstract: DERIVADOS DE QUINOXALINONA COMO ESTIMULANTES DA SECREÇÃO DE INSULINA, MÉTODOS PARA OBTENÇÃO DOS MESMOS E USO DOS MESMOS PARA O TRATAMENTO DO DIABETES. A presente invenção refere-se a derivados de quinoxalinona de fórmula (I), em que R1, R2, R3, R4, R5 e R6 são como definidos na reivindicação 1, como estimulantes da secreção de insulina. A invenção também se refere à preparação e ao uso desses derivados de quinoxalinona para a profilaxia e/ou o tratamento de diabetes e patologias associadas. Outros compostos preferidos são compostos de fórmula geral (I), em que R1, R2, R3, R4, R5 e R6 podem ser opcionalmente substituídos com um ou mais grupos selecionados de Z.
Patent AU-2002225094-B8 (AU)
Title: Oxide ion conductive ceramic membrane stacked microstructures; use for separating oxygen from air
Inventor: BACH GISELE
IPC: H01M8/02
Filed: 2001-12-18
Granted: 2007-05-17
Abstract: The invention concerns an oxide ion conductive ceramic membrane, characterized in that it comprises a non-null finite volume with non-null total thickness E, comprising a dense layer (CD) of a solid electrolyte, a so-called bonding layer (CA), of two porous electrodes (EP) and (EP'), two porous current collectors (CC) and (CC'), and at least at least a coating porous layer (ER), characterized in that the thickness E of the volume of said membrane, is equal to the sum of the thickness of each of said elements. The membrane is used for separating oxygen from air or from a gas mixture containing same.
Patent AU-2006325931-B8 (AU)
Title: Amine compound and use thereof for medical purposes
Inventor: MARUKAWA KAORU
IPC: A61K31/222
Filed: 2006-12-15
Granted: 2012-09-20
Abstract: Disclosed is a novel amine compound represented by the general formula (I) below, a pharmaceutically acceptable acid addition salt of the compound, or a hydrate or solvate of the compound or the salt, which is excellent in an immunosuppressing effect, a rejection response-suppressing effect and the like and is reduced in adverse side effects such as bradycardia. Also disclosed is a pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier. (I) wherein R represents a hydrogen atom or P(=O)(OH); X represents an oxygen or sulfur atom; Y represents CHCH or CH=CH; R represents an alkyl having 1-4 carbon atoms which is substituted by a halogen atom or a cyano; R represents an alky having 1-4 carbon atoms which may be substituted by a hydroxyl group or a halogen atom; R and R independently represent a hydrogen atom or an alkyl having 1-4 carbon atoms; and n represents 5-8.
Patent BR-102013019756-B8 (BR)
Title: Processo de síntese, compósito de nanopartículas de prata e hexaniobato de potássio e seus usos
Inventor: ITALO ODONE MAZALI
IPC: B82B3/00
Filed: 2013-08-02
Abstract: PROCESSO DE SÍNTESE, COMPÓSITO DE NANOPARTÍCULAS DE PRATA E HEXANIOBATO DE POTÁSSIO E SEUS USOS. A presente invenção se refere a um processo de síntese de compósito de nanopartículas de prata metálica na superfície de cristalitos de hexaniobato de potássio por meio da redução de íons prata localizados seletivamente na sua superfície por ação de luz UV, o compósito obtido e seus usos. O processo não utiliza reagentes tóxicos ao meio ambiente e resulta em compósito com nanopartículas localizadas na superfície, garantindo fácil ação da prata contra bactérias e liberação controlada. Os compósitos obtidos no presente pedido de patente são aplicáveis superfícies autolimpantes e antimicrobianas, interessantes para as indústrias relacionadas às áreas de saúde e de alimentos.
Patent DE-19737860-B9 (DE)
Title: Vorrichtung und Verfahren zum Einspritzen von Flüssigkristallmaterial in ein Flüssigkristallpaneel
Inventor: CHOI YOO JIN
IPC: G02F1/1341
Filed: 1997-08-29
Granted: 2008-05-15
Abstract: Vorrichtung
zum Einspritzen von Flüssigkristallmaterial
(303) in ein Flüssigkristallpaneel
(301) mit:  einer Kammer (310), in der das Flüssigkristallpaneel
(301) angeordnet werden kann, wobei der Druck der Kammer (310) veränderbar
ist;  einer Heizvorrichtung (305) zum Heizen des Flüssigkristallpaneels
(301), welche Heizvorrichtung (305) in der Kammer (310) angeordnet
ist;  einem Vorratsbehälter
(302) mit Flüssigkristallmaterial (303),
der im Abstand von der Heizvorrichtung (305) angeordnet ist; und  einer
Kühlvorrichtung
(335), die in dem Vorratsbehälter (302)
für das
Flüssigkristallmaterial
(303) angeordnet ist.
Patent EP-1303350-B9 (EP)
Inventor: VAN BERGE PETER JACOBUS
IPC: B01J23/89
Filed: 2001-07-23
Granted: 2007-05-30
Abstract: A method of treating an untreated catalyst support includes contacting an untreated catalyst support which is partially soluble in an aqueous acid and/or a neutral aqueous solution with a modifying component precursor of the formula Me(OR)x where Me is a modifying component selected from Si, Zr, Ti, Cu, Zn, Mn, Ba, Co, Ni, Na, K, Ca, Sn, Cr, Fe, Li, TI, Mg, Sr, Ga, Sb, V, Hf, Th, Ce, Ge, U, Nb, Ta, and W, R is an alkyl or acyl group, and x is an integer having a value of from 1 to 5. The modifying component is thereby introduced onto and/or into the catalyst support to form a protected modified catalyst support which is less soluble in the aqueous acid and/or the neutral aqueous solution. No calcination of the protected modified catalyst support is effected.
Patent EA-015997-B9 (EA)
Title: Method for preparing metalloaluminophosphate (meapo) molecular sieve
Inventor: VERMEIREN WALTER
IPC: B01J29/85
Filed: 2008-03-10
Abstract: The present invention also relates to a method for preparing metalloaluminophosphate (MeAPO) molecular sieve said method comprising: a) forming a reaction mixture containing a texture influencing agent (TIA), an organic templating agent (TEMP), at least a reactive inorganic source of MeO2 insoluble in the TIA, reactive sources of AlOand PO, b) crystallizing the above reaction mixture thus formed until crystals of the metalloaluminophosphate are formed, c) recovering a solid reaction product, d) washing it with water to remove the TIA and e) calcinating it to remove the organic template. In a usual embodiment said reaction mixture has a composition expressed in terms of molar oxide ratios of: TEMP/AlO= 0.3-5, more desirable 0.5-2 MeO/AlO= 0.005-2.0, more desirable 0.022-0.8 PO/AlO= 0.5-2, more desirable 0.8-1.2 TIA/AlO= 3-30, more desirable 6-20. In a usual embodiment the metalloaluminophosphate (MeAPO) molecular sieves made with the above method have a lamellar crystal morphology having an empirical chemical composition on an anhydrous basis, after synthesis and calcination, expressed by the formula HMeAlPOwherein, y+z+k=1, x≤y; y has a value ranging from 0.0008 to 0.4 and more desirable from 0.005 to 0.18; z has a value ranging from 0.25 to 0.67 and more desirable from 0.38 to 0.5525; k has a value ranging from 0.2 to 0.67 and more desirable from 0.36 to 0.54 said molecular sieve having predominantly a plate crystal morphology. In an advantageous embodiment the MeAPO made by the method of the invention have essentially a structure CHA or AEI or a mixture thereof. Preferably they have essentially the structure SAPO 18 or SAPO 34 or a mixture thereof. The present invention also relates to catalysts consisting of the above MeAPO molecular sieves made by the method of the invention or comprising the above MeAPO molecular sieves made by the method of the invention. The present invention also relates to a process for making an olefin product from an oxygen-containing, halogenide-containing or sulphur-containing organic feedstock wherein said oxygen-containing, halogenide-containing or sulphur-containing organic feedstock is contacted with the above catalyst under conditions effective to convert the oxygen-containing, halogenide-containing or sulphur-containing organic feedstock to olefin products.
Patent EA-038854-B9 (EA)
Title: Hydropower installation
Inventor: HARRIS GUY GARDNER
Filed: 2016-01-29
Abstract: The invention relates to a hydropower installation, comprising a water supply and an energy generating station, with the supply at a higher level than the energy generating station; and a duct extending between the supply and the energy generating station, wherein the energy generating station of the hydropower installation is configured based on high water velocity and low pressure. The duct may comprise plastic pipes. The duct may be arranged on a foam support and enclosed by a foam embedment. The duct may comprise at least two duct sections, with an intermediate energy generating station arranged between the duct sections of the duct. The duct may comprise internally extending protrusions, such as dimples to promote a laminar flow of fluid through the pipe. The duct may taper. Water pressure inside the duct may be maintained at atmospheric level. The proposed features all contribute to a change from pressure based systems to essentially pressure free velocity based systems.
Patent AU-2009236019-B9 (AU)
Title: Compositions useful for treating gastrointestinal motility disorders
Inventor: LANDAU STEVEN B
IPC: A61P1/06
Filed: 2009-11-11
Granted: 2011-08-25
Abstract: C:\NRPorbt\DCC\SXD\570097_.DOC. 1/1/2009 The present invention relates to method of treating a gastrointestinal motility disorder in a subject in need of treatment comprising coadministering to said subject a first 5 amount of a compound having 5-HT 3 receptor agonist activity or a pharmaceutically acceptable salt, hydrate or solvate thereof; and a second amount of at least one gastric acid suppressing agent (e.g., a proton pump inhibitor, an H2 receptor antagonist or a pharmaceutically acceptable salt, hydrate or solvate thereof, or an acid pump antagonist or pharmaceutically acceptable salt, hydrate or solvate thereof) wherein the first and second 10 amounts together comprise a therapeutically effective amount. In particular, the method is for treating GERD, including nocturnal GERD. The invention further relates to a method of treating nocturnal GERD comprising administering to a subject in need thereof a therapeutically effective amount of a compound having 5-HT 3 receptor agonist activity or a pharmaceutically acceptable salt, hydrate or solvate thereof. The invention further 15 relates to a method of increasing esophageal motility in a subject in need thereof. The method of increasing esophageal motility can be achieved by administration of a compound having a 5-HT 3 receptor agonist activity or a pharmaceutically acceptable salt, hydrate or solvate thereof. The coadministration can also be used to increase esophageal motility.
Patent AU-2018378832-B9 (AU)
Title: N4-hydroxycytidine and derivatives and anti-viral uses related thereto
Inventor: PAINTER GEORGE R
IPC: C07H19/10
Filed: 2018-12-07
Granted: 2021-05-27
Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.
Patent DE-3207126-C1 (DE)
Title: Dental impression composition
Inventor: BOHNERT HARALD
IPC: A61K6/90
Filed: 1982-02-27
Granted: 1983-06-09
Abstract: Production of an alginate-based dental impression composition by agglomeration of the powdered individual ingredients with the aid of an alcohol-soluble binder to prevent dusting during dental use.
Patent DE-3242965-C1 (DE)
Inventor: MAIER GERHARD
IPC: H03J3/32
Filed: 1982-11-20
Granted: 1984-05-30
Abstract: Upon the selection of a desired reception channel, the tuner oscillator (9) is switched off, while an oscillator (15) simulating reception signals is switched on at the antenna input and is switched alternatingly on at least two frequencies within the reception channel. A R.F. signal demodulator (16) provides to a microprocessor (13) a criterion to indicate an optimum tuning. The obtained tuning voltage is conducted to the R.F. circles (3-5) to be adjusted after digital/analogue transformation (18-20), up to the end of the adjustment of all circles.